MCID: END047
MIFTS: 51

Endophthalmitis

Categories: Eye diseases, Rare diseases

Aliases & Classifications for Endophthalmitis

MalaCards integrated aliases for Endophthalmitis:

Name: Endophthalmitis 12 59 55 44 15 73

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Eye diseases
Orphanet: 59  
Rare eye diseases


External Ids:

Disease Ontology 12 DOID:4692
MeSH 44 D009877
NCIt 50 C34586
SNOMED-CT 68 1847009 82255004
Orphanet 59 ORPHA199323
ICD10 via Orphanet 34 H44.0 H44.1
MESH via Orphanet 45 D009877
UMLS via Orphanet 74 C0014236
ICD10 33 H45.1
UMLS 73 C0014236

Summaries for Endophthalmitis

Disease Ontology : 12 A globe disease that is characterized by inflammation of the inside of the eye.

MalaCards based summary : Endophthalmitis is related to acute endophthalmitis and purulent endophthalmitis, and has symptoms including redness or discharge of eye An important gene associated with Endophthalmitis is CARD9 (Caspase Recruitment Domain Family Member 9), and among its related pathways/superpathways are Development VEGF signaling via VEGFR2 - generic cascades and Fluid shear stress and atherosclerosis. The drugs Lidocaine and Cefazolin have been mentioned in the context of this disorder. Affiliated tissues include eye, endothelial and liver, and related phenotypes are hematopoietic system and immune system

Wikipedia : 76 Endophthalmitis is an inflammation of the interior of the eye. It is a possible complication of all... more...

Related Diseases for Endophthalmitis

Diseases in the Endophthalmitis family:

Chronic Endophthalmitis Acute Endophthalmitis

Diseases related to Endophthalmitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 214)
# Related Disease Score Top Affiliating Genes
1 acute endophthalmitis 33.8 PRF1 VEGFA
2 purulent endophthalmitis 33.2 MRAP OPTN PRF1 VEGFA
3 chorioretinitis 30.1 MRAP OPTN
4 corneal abscess 29.9 DEFB1 PLG
5 yemenite deaf-blind hypopigmentation syndrome 29.7 OPTN VEGFA
6 neovascular glaucoma 29.6 OPTN VEGFA
7 macular dystrophy, dominant cystoid 29.6 MRAP VEGFA
8 vitreous detachment 29.6 PLG VEGFA
9 macular retinal edema 29.4 ICAM1 MRAP VEGFA
10 chronic endophthalmitis 12.4
11 phacoanaphylactic uveitis 11.4
12 cataract 10.8
13 sympathetic ophthalmia 10.7
14 uveitis 10.3
15 meningitis 10.3
16 hypopyon 10.2
17 retinal detachment 10.2
18 endocarditis 10.2
19 heterophyiasis 10.2 ICAM1 SELE
20 lymphocytic vasculitis 10.2 ICAM1 SELE
21 keratitis, hereditary 10.2
22 scleritis 10.2
23 cellulitis 10.2
24 mooren's ulcer 10.2 ICAM1 SELE
25 hymenolepiasis 10.2 ICAM1 SELE
26 plummer's disease 10.2 ICAM1 SELE
27 macrophage activation syndrome 10.2 HMGB1 PRF1
28 subendocardial myocardial infarction 10.2 ICAM1 SELE
29 actinic prurigo 10.2 ICAM1 SELE
30 orbital cellulitis 10.2
31 fungal keratitis 10.2
32 rheumatoid vasculitis 10.2 ICAM1 SELE
33 hypersensitivity reaction type iii disease 10.1 ICAM1 SELE
34 osteonecrosis of the jaw 10.1 DEFB1 VEGFA
35 critical limb ischemia 10.1 SELE VEGFA
36 leukocyte adhesion deficiency, type i 10.1 ICAM1 SELE
37 candida glabrata 10.1
38 localized scleroderma 10.1 DEFB1 SELE
39 plasmodium vivax malaria 10.1 ICAM1 SELE
40 vertebrobasilar insufficiency 10.1 ICAM1 SELE
41 retinitis 10.1
42 osgood-schlatter's disease 10.1 MRAP PRF1
43 inclusion conjunctivitis 10.1 HMGB1 MRAP
44 strabismus 10.1
45 candidiasis 10.1
46 vasculitis 10.1
47 mycobacterium chelonae 10.1
48 diabetic macular edema 10.1 ICAM1 VEGFA
49 cutaneous lupus erythematosus 10.1 ICAM1 SELE
50 macular degeneration, age-related, 1 10.0

Graphical network of the top 20 diseases related to Endophthalmitis:



Diseases related to Endophthalmitis

Symptoms & Phenotypes for Endophthalmitis

UMLS symptoms related to Endophthalmitis:


redness or discharge of eye

MGI Mouse Phenotypes related to Endophthalmitis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.7 CARD9 GON4L ICAM1 PLG PRF1 SELE
2 immune system MP:0005387 9.56 CARD9 GON4L ICAM1 OPTN PLG PRF1
3 neoplasm MP:0002006 9.02 GON4L ICAM1 PLG PRF1 VEGFA

Drugs & Therapeutics for Endophthalmitis

Drugs for Endophthalmitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 198)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lidocaine Approved, Vet_approved Phase 4,Not Applicable 137-58-6 3676
2
Cefazolin Approved Phase 4,Not Applicable 25953-19-9 656510 33255
3
Polyestradiol phosphate Approved Phase 4,Phase 2,Phase 3,Not Applicable 28014-46-2
4
Moxifloxacin Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 354812-41-2, 151096-09-2 152946
5
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 50-28-2 5757
6
Norgestimate Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 35189-28-7 6540478
7 Estradiol valerate Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 979-32-8
8
Ethinyl Estradiol Approved Phase 4,Phase 2,Phase 3,Not Applicable 57-63-6 5991
9
Methylprednisolone Approved, Vet_approved Phase 4,Phase 1,Phase 2,Not Applicable 83-43-2 6741
10
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 1,Phase 2,Not Applicable 302-25-0
11
Methylprednisolone hemisuccinate Approved Phase 4,Phase 1,Phase 2,Not Applicable 2921-57-5
12
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 124-94-7 31307
13
Prednisolone Approved, Vet_approved Phase 4,Phase 1,Phase 2,Not Applicable 50-24-8 5755
14
Ranibizumab Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 347396-82-1 459903
15
Bevacizumab Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 216974-75-3
16
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 1 22916-47-8 4189
17
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1 50-02-2 5743
18
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1 1177-87-3
19
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
20
Povidone Approved Phase 4,Not Applicable 9003-39-8
21
Iodine Approved, Investigational Phase 4,Not Applicable 7553-56-2 807
22
Povidone-iodine Approved Phase 4,Phase 3,Not Applicable 25655-41-8
23
Levofloxacin Approved, Investigational Phase 4,Not Applicable 100986-85-4 149096
24
Ofloxacin Approved Phase 4,Not Applicable 82419-36-1 4583
25
Prednisolone hemisuccinate Experimental Phase 4,Phase 1,Phase 2,Not Applicable 2920-86-7
26 Central Nervous System Depressants Phase 4,Not Applicable
27 Anesthetics, Local Phase 4,Not Applicable
28 Cephalosporins Phase 4
29 Anti-Arrhythmia Agents Phase 4,Not Applicable
30 Diuretics, Potassium Sparing Phase 4,Not Applicable
31 Antitubercular Agents Phase 4,Phase 3,Not Applicable
32 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Not Applicable
33 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
34 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
35 Anesthetics Phase 4,Phase 3,Not Applicable
36 Sodium Channel Blockers Phase 4,Not Applicable
37 Pharmaceutical Solutions Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
38 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
39 Ophthalmic Solutions Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
40 Estradiol 3-benzoate Phase 4,Phase 2,Phase 3,Not Applicable
41 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Not Applicable
42 Norgestimate, ethinyl estradiol drug combination Phase 4,Phase 2,Phase 3,Not Applicable
43 Contraceptives, Oral Phase 4,Phase 2,Phase 3,Not Applicable
44 Contraceptive Agents Phase 4,Phase 2,Phase 3,Not Applicable
45 Contraceptives, Oral, Combined Phase 4,Phase 2,Phase 3,Not Applicable
46 Estradiol 17 beta-cypionate Phase 4,Phase 2,Phase 3,Not Applicable
47 Fluoroquinolones Phase 4,Phase 2,Phase 3,Not Applicable
48 Topoisomerase Inhibitors Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
49 Protective Agents Phase 4,Phase 1,Phase 2,Not Applicable
50 Antiemetics Phase 4,Phase 3,Not Applicable

Interventional clinical trials:

(show top 50) (show all 144)
# Name Status NCT ID Phase Drugs
1 Cefazolin-Lidocaine Combination Solution to Reduce Antibiotic Pain Unknown status NCT02324166 Phase 4 Cefazolin;Lidocaine
2 Dosage Study for Vigamox Eye Drops Prior to Intravitreal Injections Unknown status NCT00690313 Phase 4 Vigamox
3 IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical Steroids Unknown status NCT00744666 Phase 4 Prednisolone 1% topical eye drops
4 Effects of Ranibizumab to Delay or Regression Non-proliferative Diabetic Retinopathy(NPDR) With DME Assessed by Microaneurysm Changes: A Pilot Study Unknown status NCT02834663 Phase 4 Lucentis
5 A Two Chemoprophylaxis Approaches After Phacoemulsification Surgery Completed NCT03634852 Phase 4 Moxifloxacin hydrochloride 0.5% eye drops;Dexamethasone 0.1% eye drops;Intracameral Moxifloxacin 0.1%;Subconjunctival Triamcinolone acetonide 4 mg /0.4 ml
6 Prophylaxis of Acute Post-Traumatic Bacterial Endophthalmitis Completed NCT00398658 Phase 4 gentamycin and clindamycin
7 Povidone-iodine Antisepsis for Strabismus Surgery Completed NCT00461656 Phase 4 Preoperative conjunctival irrigation with 5% or 1.25% PI
8 Evaluation of the Effect of Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using OCTA Completed NCT03246152 Phase 4 Bevacizumab
9 Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery Completed NCT01440751 Phase 4 Use of Mitomycin-C (MMC) in trabeculectomy
10 Comparative Efficacy of Different Regimens of PVPI 5% Eye Drops Instillation in Reducing Conjunctival Bacterial Flora Completed NCT01739920 Phase 4
11 Effectiveness of Topical 0.5% Levofloxacin to Reduce the Conjunctival Bacterial Flora Before Intraocular Surgery Completed NCT00491049 Phase 4 0.5% levofloxacin eye drops
12 Aurolab Hydrophobic Foldable Intraocular Lens Study Completed NCT00449267 Phase 4
13 Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment Completed NCT01722656 Phase 4 Aflibercept
14 Evaluation of Macular Changes After Intracameral Moxifloxacin for Prevention of Endophthalmitis Recruiting NCT03363295 Phase 4 Moxifloxacin Injection
15 Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab Recruiting NCT02665689 Phase 4 ranibizumab
16 Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients Withdrawn NCT00304772 Phase 4 Fluconazole;Micafungin
17 The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis Unknown status NCT00012506 Phase 3 TNFR:Fc
18 Double-dose Ranibizumab for Polypoidal Choroidal Vasculopathy Unknown status NCT02769169 Phase 2, Phase 3 Lucentis® (Raibizumab) double-dose;Lucentis® (Raibizumab) regular-dose
19 Interest of Intravitreal Corticotherapy as the First-line Treatment for Post-operative Endophthalmitis Completed NCT01768078 Phase 3
20 Endophthalmitis Vitrectomy Study (EVS) Completed NCT00000130 Phase 3 Intravitreal Antibiotics
21 Clinical Trial of Eye Prophylaxis in the Newborn Completed NCT00000120 Phase 3 Erythromycin Ointment;Silver Nitrate Drops
22 Retaane® in Age-Related Macular Degeneration Completed NCT00569569 Phase 2, Phase 3 juxtascleral depot injection of Retaane
23 Systemic Avastin Therapy in Age-Related Macular Degeneration Completed NCT00531024 Phase 2, Phase 3 Bevacizumab;Sodium Chloride
24 Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO) Completed NCT00942864 Phase 3 ranibizumab
25 PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial Completed NCT02374060 Phase 3 Periocular triamcinolone 40 mg;Intravitreal triamcinolone 4 mg;Dexamethasone intravitreal implant
26 PRevention of Macular EDema After Cataract Surgery Completed NCT01774474 Phase 3 Bromfenac;Dexamethasone;Bevacizumab;Triamcinolone Acetonide
27 Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery Recruiting NCT03739528 Phase 3 Levofloxacin + dexamethasone followed by dexamethasone;Tobramycin + Dexamethasone
28 Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial Recruiting NCT02623426 Phase 3 Dexamethasone intravitreal implant 0.7 mg;Intravitreal Methotrexate 400 µg;Intravitreal Ranibizumab 0.5 mg
29 Efficacy and Tolerance Comparison Between Subconjunctival Injection of Triamcinolone and Intravitreal Implant of Dexamethasone for the Treatment of Inflammatory Macular Edema Recruiting NCT02556424 Phase 3 Dexamethasone;Triamcinolone
30 A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behcet's Disease Active, not recruiting NCT02307513 Phase 3 Apremilast (CC-10004);Placebo
31 Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery Not yet recruiting NCT03244072 Phase 2, Phase 3 Moxifloxacin;Placebo
32 Intracameral Antibiotic Safety Study Not yet recruiting NCT02590523 Phase 3 Vancomycin;Moxifloxacin;Placebo
33 Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis. Terminated NCT02770729 Phase 3 Moxifloxacin;No injection of moxifloxacin
34 Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa Terminated NCT01103063 Phase 3 Azithromycin plus chloroquine;sulfadoxine-pyrimethamine
35 A Study of the Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic Retinopathy Withdrawn NCT01589718 Phase 3 Macugen;Sham
36 The Effect of Intravitral Injection of Triamcinolone Combined With Cataract Surgery (Phacoemulsification) on Diabetic Macular Edema and Diabetic Retinopathy Unknown status NCT00849537 Phase 1, Phase 2 Triamcinolone
37 Endolaserless Vitrectomy With Intravitreal IAI for PDR-Related VH Unknown status NCT02976012 Phase 1, Phase 2 Aflibercept
38 Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy Unknown status NCT01469156 Phase 1, Phase 2 ranibizumab 0.5 or 2.0 mg/0.05 cc
39 Ranibizumab For Persistent Diabetic Macular Edema After Bevacizumab Unknown status NCT01845844 Phase 1, Phase 2 Ranibizumab 0.3mg/0.05cc
40 Safety Study of Conventional Versus Micropulse Transscleral Cyclophotocoagulation in Treating End-Stage Glaucoma Unknown status NCT00349414 Phase 1, Phase 2
41 Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis Completed NCT02595359 Phase 2 Moxifloxacin
42 TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis Completed NCT00001862 Phase 2 Enbrel
43 Modified Intraocular Lens to Reduce Eye Inflammation After Cataract Surgery in Uveitis Patients Completed NCT00001311 Phase 2
44 Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration Completed NCT00805233 Phase 2 combination ranibizumab + bromfenac;ranibizumab injection alone
45 Ranibizumab and Reduced Fluence PDT for AMD Completed NCT00527475 Phase 2 ranibizumab;verteporfin
46 20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD) Completed NCT01175395 Phase 1, Phase 2 IBI-20089/Lucentis
47 Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis Completed NCT00070759 Phase 2 Daclizumab
48 HAT in Eye Complications of Behcet's Disease Completed NCT00001865 Phase 2 Daclizumab
49 Daclizumab Injections to Treat Non-Infectious Sight-Threatening Uveitis Completed NCT00043667 Phase 2 Daclizumab
50 Trabeculectomy With Ologen Collagen Implant vs Trabeculectomy With Provisc in Steroid Induced Glaucoma Completed NCT01912638 Phase 1, Phase 2 Provisc

Search NIH Clinical Center for Endophthalmitis

Cochrane evidence based reviews: endophthalmitis

Genetic Tests for Endophthalmitis

Anatomical Context for Endophthalmitis

MalaCards organs/tissues related to Endophthalmitis:

41
Eye, Endothelial, Liver, Testes, Lung, Myeloid, Pituitary

Publications for Endophthalmitis

Articles related to Endophthalmitis:

(show top 50) (show all 1545)
# Title Authors Year
1
Acanthamoeba endophthalmitis during treatment for cutaneous disease in a renal transplant patient. ( 29359845 )
2018
2
Post-surgical versus post-intravitreal injection endophthalmitis: changing patterns in causative flora. ( 29931722 )
2018
3
Streptococcus Dysgalactiae Subspecies Equisimilis Endogenous Endophthalmitis Associated with Aortic Valve Abscess. ( 29969334 )
2018
4
Stromal Keratitis with Endophthalmitis Caused by Vittaforma Corneae in an Immunocompetent Patient: A Case Report. ( 29672246 )
2018
5
Postsurgical Cataract Prophylaxis With Intravitreal "Triamcinolone-Moxifloxacin" May Not Be Optimal For Preventing Endophthalmitis. ( 29944493 )
2018
6
Surgical preferences in the management of recalcitrant endophthalmitis. ( 29300514 )
2018
7
Epidemiology and Mortality-Related Prognostic Factors in Endophthalmitis. ( 29847653 )
2018
8
Change in Nationwide Incidence of Post-Cataract Surgery Endophthalmitis: Korean Cohort Study from 2002 to 2013. ( 29953316 )
2018
9
Review of Intraocular Pharmacokinetics of Anti-Infectives Commonly Used in the Treatment of Infectious Endophthalmitis. ( 29844284 )
2018
10
Endophthalmitis in patients co-infected by HIV and sporotrichosis: a systematic review of published case reports. ( 29880916 )
2018
11
Antibiotic prophylaxis for preventing endophthalmitis after intravitreal injection: a systematic review. ( 29891901 )
2018
12
Endogenous <i>Cryptococcus neoformans</i> endophthalmitis with subretinal abscess in a HIV-infected man. ( 29941759 )
2018
13
Endophthalmitis Following XEN Stent Exposure. ( 29952822 )
2018
14
The Routine Use of Intracameral Antibiotics to Prevent Endophthalmitis After Cataract Surgery: How Good is the Evidence? ( 29974362 )
2018
15
Human Endophthalmitis Caused By Pseudorabies Virus Infection, China, 2017. ( 29774834 )
2018
16
Management of <i>Candida glabrata</i> infectious crystalline keratopathy with endophthalmitis following penetrating keratoplasty. ( 29941758 )
2018
17
Trends in treatment strategies for suspected bacterial endophthalmitis. ( 29417214 )
2018
18
Endophthalmitis caused by Purpureocillium lilacinum. ( 29366691 )
2018
19
Incidence and characteristics of acute-onset postoperative bacterial and sterile endophthalmitis in dogs following elective phacoemulsification: 1,447 cases (1995-2015). ( 29963957 )
2018
20
Another perspective on the treatment of postoperative endophthalmitis: Unclear evidence for the role of vitrectomy. ( 29862645 )
2018
21
Endophthalmitis and Mycotic Aneurysm: The Only Clues to Underlying Endocarditis. ( 29849250 )
2018
22
Endophthalmitis following Strabismus Surgery: IPOSC Global Study. ( 29966454 )
2018
23
XEN Implant-Related Endophthalmitis. ( 29389405 )
2018
24
A British Ophthalmological Surveillance Unit Study on metastatic endogenous endophthalmitis. ( 29328066 )
2018
25
Pediatric Infectious Endophthalmitis: A Case Series. ( 29378081 )
2018
26
Is combined cataract surgery associated with acute postoperative endophthalmitis? A nationwide study from 2005 to 2014. ( 29925513 )
2018
27
Exophiala dermatitidis Endophthalmitis: Case Report and Literature Review. ( 29374798 )
2018
28
A cluster of nontuberculous mycobacterial endophthalmitis (NTME) cases after cataract surgery: clinical features and treatment outcomes. ( 29844367 )
2018
29
Late-onset postoperative Mycobacterium haemophilum endophthalmitis masquerading as inflammatory uveitis: a case report. ( 29415658 )
2018
30
Bacteriology and cefuroxime-resistance in endophthalmitis following cataract surgery before and after the introduction of prophylactic intracameral cefuroxime: a retrospective single-centre study. ( 29432821 )
2018
31
Incidence of Endophthalmitis after Intravitreal Injections: Risk Factors, Microbiology Profile, and Clinical Outcomes. ( 29437495 )
2018
32
Incidence, microbiology, and outcomes of endophthalmitis after 111,876 pars plana vitrectomies at a single, tertiary eye care hospital. ( 29338030 )
2018
33
Incidence of endophthalmitis after 23-gauge pars plana vitrectomy. ( 29361927 )
2018
34
INCIDENCE OF ENDOPHTHALMITIS AFTER VITRECTOMY: A Systematic Review and Meta-analysis. ( 29370034 )
2018
35
Diagnostic performance of blood culture bottles for vitreous culture compared to conventional microbiological cultures in patients with suspected endophthalmitis. ( 29318458 )
2018
36
Endophthalmitis Following Pediatric Cataract Surgery: An International Pediatric Ophthalmology and Strabismus Council Global Perspective. ( 28991343 )
2018
37
Utility of MALDI-TOF mass spectrometry in an outbreak investigation of acute endophthalmitis following intravitreal injection. ( 29605188 )
2018
38
Association of Acute Endophthalmitis With Intravitreal Injections of Corticosteroids or Anti-Vascular Growth Factor Agents in a Nationwide Study in France. ( 30242325 )
2018
39
Aspergillus aortitis in an immunocompetent patient presenting with acute endophthalmitis. ( 30344969 )
2018
40
Emergency management: acute endophthalmitis. ( 30487688 )
2018
41
Fusarium Endophthalmitis, Unusual and Challenging Infection in an Acute Leukemia Patient. ( 29725549 )
2018
42
Recurrent Aspergillus terreus Endophthalmitis from Focal Bronchiectasis. ( 27715366 )
2018
43
Fibrin Web in a Patient with Candida glabrata Endophthalmitis. ( 29458827 )
2018
44
Candida Endophthalmitis After Descemet Stripping Automated Endothelial Keratoplasty With Grafts From Both Eyes of a Donor With Possible Systemic Candidiasis. ( 29303885 )
2018
45
Post-cataract surgery endophthalmitis: the role of prophylactic antibiotic eye drops. ( 30456823 )
2018
46
Endophthalmitis incidence of cancer patients after cataract surgery: A nationwide matched cohort study in Taiwan. ( 30529565 )
2018
47
The Malaysian cataract surgery registry: incidence and risk factors of postoperative infectious endophthalmitis over a 7-year period. ( 30364221 )
2018
48
Infectious postoperative endophthalmitis after cataract surgery performed over 7 years. The role of azithromycin versus ciprofloxacin eye drops. ( 30421880 )
2018
49
Acute-onset postoperative endophthalmitis after cataract surgery and transzonular intravitreal triamcinolone-moxifloxacin. ( 30241719 )
2018
50
Treatment outcomes of post cataract surgery endophthalmitis in a tertiary referral center in Iran. ( 29988899 )
2018

Variations for Endophthalmitis

Expression for Endophthalmitis

Search GEO for disease gene expression data for Endophthalmitis.

Pathways for Endophthalmitis

GO Terms for Endophthalmitis

Cellular components related to Endophthalmitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cell surface GO:0009986 9.26 HMGB1 ICAM1 PLG VEGFA
2 extracellular space GO:0005615 9.1 DEFB1 HMGB1 ICAM1 PLG SELE VEGFA

Biological processes related to Endophthalmitis according to GeneCards Suite gene sharing:

(show all 11)
# Name GO ID Score Top Affiliating Genes
1 innate immune response GO:0045087 9.56 CARD9 DEFB1 HMGB1 OPTN
2 positive regulation of blood vessel endothelial cell migration GO:0043536 9.49 HMGB1 VEGFA
3 positive chemotaxis GO:0050918 9.48 HMGB1 VEGFA
4 heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules GO:0007157 9.46 ICAM1 SELE
5 positive regulation of autophagy GO:0010508 9.43 HMGB1 OPTN
6 ovarian follicle development GO:0001541 9.4 ICAM1 VEGFA
7 leukocyte cell-cell adhesion GO:0007159 9.37 ICAM1 SELE
8 positive regulation of sprouting angiogenesis GO:1903672 9.32 HMGB1 VEGFA
9 positive regulation of innate immune response GO:0045089 9.16 CARD9 HMGB1
10 positive regulation of receptor internalization GO:0002092 8.96 SELE VEGFA
11 endothelial cell chemotaxis GO:0035767 8.62 HMGB1 VEGFA

Molecular functions related to Endophthalmitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 identical protein binding GO:0042802 9.02 DEFB1 MRAP OPTN PRF1 VEGFA
2 chemoattractant activity GO:0042056 8.96 HMGB1 VEGFA

Sources for Endophthalmitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....